Queue | Square | Year of completion |
---|---|---|
I | 31 555 м² | 2020 |
II | 11 420 м² | Under construction |
BIOCAD is one of Russia's largest biotechnology companies. It produces 60 drugs for the treatment of oncological, autoimmune and infectious diseases. Products are manufactured at 4 owned pharmaceutical and biotechnology production sites in St. Petersburg and the Moscow region. The company employs around 2,500 people.
In 2020, PSO-13 completed construction of the 1st stage of the fifth, largest, BIOCAD plant in the @Technopolis Moscow@ special economic zone in Zelenograd.
Advanced technological and engineering solutions, unparalleled in Russia, were used in the project.
At a site of 6.7 hectares, a single multifunctional building contains:
- 2-storey production and laboratory block
- Automated warehouse of 21.4 m height
- Handling area
- 3-floor administrative and household block
- 2 checkpoints
Construction area 31,555.0 m. Total area of buildings and structures 42 975 m². The mayor of Moscow, Sergei Sobyanin, attended the opening of the plant.
Now PSO-13 has started Stage 2 of the fifth, largest, factory BIOCAD